2293 — Bamboos Health Care Holdings Income Statement
0.000.00%
Last trade - 00:00
- HK$245.50m
- HK$236.89m
- HK$126.56m
- 90
- 83
- 20
- 76
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 78.5 | 72.3 | 110 | 140 | 127 |
Cost of Revenue | |||||
Gross Profit | 78.1 | 70.3 | 109 | 136 | 117 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 30.3 | 36.2 | 36 | 67.1 | 66.7 |
Operating Profit | 48.2 | 36.1 | 73.7 | 73.2 | 59.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 47.1 | 36.2 | 73.5 | 72.4 | 58.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 38.9 | 30.7 | 61 | 58.6 | 46.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 38.9 | 30.7 | 61 | 58.6 | 46.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 38.9 | 30.7 | 61 | 58.6 | 46.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.092 | 0.077 | 0.158 | 0.146 | 0.117 |
Dividends per Share | |||||
Special Dividends per Share |